Evaxion Biotech A/S (ADR) Live Stock Price Today, Share Analysis and Chart

Name: Evaxion Biotech A/S - ADR: Is Infosys Ltd. worth buying?
Item: Evaxion Biotech A/S - ADR
Rating: 1.54583325
Author: Trendlyne DVM scores

about

Evaxion AS is a clinical-stage TechBio company developing novel vaccines with its proprietary, clinically validated and scalable AI platform, AI-Immunology. The platform harnesses the power of artificial intelligence to decode the human immune system...

3.92 -0.20 (-4.85%)

67.74% Fall from 52W High

26,210

XNAS Volume

XNAS 15 May, 2026 5:30 PM (EDT)

Not Eligible

Expensive Valuation

20.8 / 100

Technically Neutral

41.0 / 100

1Yr Price target upside is 187%

4 analysts

Evaxion Biotech A/S (ADR) Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Evaxion Biotech A/S (ADR) Live Stock Price Today, Share Analysis and Chart

Evaxion AS is a clinical-stage TechBio company developing novel vaccines with its proprietary, clinically validated and scalable AI platform, AI-Immunology. The platform harnesses the power of artificial intelligence to decode the human immune system...

67.74% Fall from 52W High

SWOT Analysis

Evaxion Biotech A/S (ADR) Live Price Chart